You are here » Home » Companies » Company Overview » Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Ltd.

BSE: 532150	Sector: Health care
NSE: INDRAMEDCO	ISIN Code: INE681B01017

BSE 00:00 | 15 Jan

57.10

0
(0.00%)

OPEN

58.50

HIGH

58.50

LOW

56.70

NSE 00:00 | 15 Jan

57.15

0
(0.00%)

OPEN

57.15

HIGH

58.00

LOW

56.65

Add to Watchlist | Add to Portfolio

OPEN	58.50
PREVIOUS CLOSE	57.10
VOLUME	22121
52-Week high	69.80
52-Week low	27.45
P/E
Mkt Cap.(Rs cr)	523
Buy Price	56.50
Buy Qty	316.00
Sell Price	57.30
Sell Qty	100.00

OPEN	58.50
CLOSE	57.10
VOLUME	22121
52-Week high	69.80
52-Week low	27.45
P/E
Mkt Cap.(Rs cr)	523
Buy Price	56.50
Buy Qty	316.00
Sell Price	57.30
Sell Qty	100.00

Click here for interactive graph

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) - News Sector

Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec

7.22 am | 15 Jan 2021 | Business Standard

The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

1.44 pm | 14 Jan 2021 | Business Standard

Healthcare companies to post decent growth in revenues in Q3FY21
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

1.44 pm | 14 Jan 2021 | Business Standard

Healthcare companies to post decent growth in revenues in Q3FY21
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

1.44 pm | 14 Jan 2021 | Business Standard

Healthcare companies to post decent growth in revenues in Q3FY21
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

1.44 pm | 14 Jan 2021 | Business Standard

Healthcare companies to post decent growth in revenues in Q3FY21
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

1.44 pm | 14 Jan 2021 | Business Standard

Healthcare companies to post decent growth in revenues in Q3FY21
Testing recovery gains factored in Thyrocare Technologies stock

11.57 pm | 12 Jan 2021 | Business Standard

Margin pressures and valuations would limit major upsides
Stocks to watch: GAIL, Tata Motors, Dishman Carbogen, DRL, Karnataka Bank

8.46 am | 12 Jan 2021 | Business Standard

Jaguar Land Rover's retail sales fell 9 per cent YoY to 1,28,469 units in the October-December quarter
Stocks to watch: GAIL, Tata Motors, Dishman Carbogen, DRL, Karnataka Bank

8.46 am | 12 Jan 2021 | Business Standard

Jaguar Land Rover's retail sales fell 9 per cent YoY to 1,28,469 units in the October-December quarter
Pfizer compiling data to answer DCGI queries on coronavirus vaccine

1.51 am | 12 Jan 2021 | Business Standard

Drug major clarifies it could not present itself before the SEC because of short notice and time zone issues
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

1.11 am | 11 Jan 2021 | Business Standard

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

1.11 am | 11 Jan 2021 | Business Standard

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

1.11 am | 11 Jan 2021 | Business Standard

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

1.11 am | 11 Jan 2021 | Business Standard

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

1.11 am | 11 Jan 2021 | Business Standard

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
Piramal contests US-based Oaktree Capital's offer for bankrupt DHFL

10.19 pm | 8 Jan 2021 | Business Standard

The tier I capital of DHFL has already been completely written off and the existing lenders will be taking a substantial write-down on their loans
Strides dips 6% from high on profit booking as Aditya Puri joins as advisor

10.48 am | 8 Jan 2021 | Business Standard

In the past six months, the stock has zoomed 130 per cent, as compared to 33 per cent rally in the S&P BSE Sensex
Sun Pharma rises 3%, hits over 2-year high on steady earnings visibility

10.33 am | 8 Jan 2021 | Business Standard

The board of directors of Sun Pharma are scheduled to meet on January 29, 2021 to consider and approve Q3 results
Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ

9.46 am | 8 Jan 2021 | Business Standard

ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, valuing Biocon Biologics at a post money valuation of arou...
Stocks to watch: TCS, Biocon, Bharat Rasayan, Vodafone Idea, Tata Power

8.39 am | 8 Jan 2021 | Business Standard

Biocon announced that its subsidiary Biocon Biologics has approved a primary equity investment by Abu Dhabi-based ADQ, one of the region's largest hol...